Trial Profile
Study to evaluate the effect of Iloprost on T-lymphocyte regulation pathway in patients with early systemic sclerosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Jun 2015
Price :
$35
*
At a glance
- Drugs Iloprost (Primary)
- Indications Systemic scleroderma
- Focus Pharmacodynamics
- 22 Jun 2015 New trial record